MentionFox
Home › funding signals › Retropsoas Technologies, LLC
Form D · on the record

Retropsoas Technologies — $3.11M Form D filing, January 2025

Before you sell to, join or invest in Retropsoas Technologies, LLC

MentionFox check on Retropsoas Technologies, LLC: only 2 sources on file so far (checked 6 November 2026). Run a full check before you rely on it. mentionfox.com/c/funding/retropsoas-technologies-llc-form-d-25000001

Check Retropsoas Technologies, LLC before you sell to, join or invest Free, no sign-up: every record on file, each linked to its source.

What do you want to do about Retropsoas Technologies, LLC?

Retropsoas Technologies, LLC filed an amended Form D with the Securities and Exchange Commission on 2025-01-27.

Retropsoas Technologies, LLC filed an amended Form D notice of an exempt securities offering with the SEC on January 27, 2025. The filing reports $3.11M sold. Its industry group is Other Health Care. It names Nicholas Poulos (CEO; Manager of Poulos Technologies, LLC (the Manager of Retropsoas Technologies, LLC)) (SEC Form D/A, January 27, 2025).

125 companies raised this week.

Companies that just raised money, and the people to call. Before you unlock: the company, the amount, the date and what is inside (for example 2 people, phone, LinkedIn). After: the officers and directors the filing names with their roles, how to reach the company, and a person's email only when we found one.

Andersen Aggregator LLC$1.9BBusiness services
AT Umbrella LLC$1.9BBusiness services
Legora, Inc.$221MAI and software
MD INVESTMENT LLC$169MBusiness services
Serval Inc.$149MAI and software
Check one company free

5 more Other Health Care raises within 90 days of this one ↓

Is this your company?

Key facts

Run the free check on Retropsoas Technologies, LLC →

Sell to companies like Retropsoas Technologies, LLC? Enter your website and see 10 with a filed reason to buy from you this month. Free.

Opens in a new tab. No signup.

Retropsoas Technologies, LLC

New Form D on file · 2025-01-27 · the record

$3.11M
raise on the record
D/A
filing
38
investors in
MISSOURI
based
Open the record →

What the record says

FilingForm D/A (amended)
Filed2025-01-27
Industry groupOther Health Care
Entity typeLimited Liability Company
Incorporated inMISSOURI
BasedFRONTENAC, MISSOURI
CIK1798662
Accession0001798662-26-000001

Pitching, partnering or investing alongside them? See who really runs and owns Retropsoas Technologies, LLC.

Free to see. No signup.

Keep reading

More on the people and the money behind Retropsoas Technologies, LLC, from the filings we hold.

More raises like this

Other Health Care raises filed within 90 days of this one, largest first.

What do you want to do with Retropsoas Technologies, LLC?

Get the full cited report on Retropsoas Technologies, LLC

What the filing shows about Retropsoas Technologies, LLC

  • 38 investors had already put money in when it filed.

Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.

Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)

A Full Report on Retropsoas Technologies, LLC: verified, sourced, every claim cited, ready in a few minutes. See pricing.

See a sample report

Who the filing names, and in what role

The filing gives Retropsoas Technologies, LLC's address as 34 Countryside Lane, Frontenac, MO 63131.

Amended on 2026-05-04: the offering size changed from $2,000,000 to $4,500,000; the amount sold changed from $1,050,000 to $3,112,500; the number of investors changed from 2 to 38; sales commissions changed from $0 to $1,750. Figures on this page are from the amendment. Amended filing · Original filing

What the filing says

  • Offered: $4,500,000. Sold: $3,112,500. Left to sell: $1,387,500. (filing)
  • Investors: 38 had already invested, 25 of them not accredited. (filing)
  • Date of first sale: January 15, 2025. (filing)
  • Types of securities: Equity; Debt. (filing)
  • Item 16: the filing reports that none of the proceeds goes to executive officers, directors or promoters. It adds: “Proceeds are for capital expenditures and working capital needs. The number above excludes the use of proceeds for ordinary course salary payments to executive officers.” (filing)

This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.

Order the Full Report on Retropsoas Technologies, LLC See pricing

Is Retropsoas Technologies, LLC a real, registered company?

Retropsoas Technologies, LLC is a registered filer with the SEC (CIK 1798662) and has filed since 2022-12-30. 5 filings are on record, the latest on 2026-05-04.

A filing shows the company exists and what it reports about itself. It is not an audit or a rating.

Who runs Retropsoas Technologies, LLC?

Retropsoas Technologies, LLC's Form D of 2025-01-27 names Nicholas Poulos as its officers, directors or promoters.

How much has Retropsoas Technologies, LLC raised?

Its new offerings report $1.05M sold across 1 offering, as its own filings state.

Filing history · 5 filings on this registrant
Form D/A, amended · 2022-12-30 · $1.28MForm D · 2025-01-27 · $1.05M · this pageForm D/A, amended · 2025-08-22 · $1.15MForm D/A, amended · 2025-12-29 · $1.43MForm D/A, amended · 2026-05-04 · $3.11M 2022-12-30 2026-05-04

A hollow marker is an amendment (Form D/A); a solid one is an original Form D. The larger marker is the filing this page is about.

Other Health Care · by week

Trailing twelve months. 861 filings in Other Health Care, totalled by week.

Want the whole picture on Retropsoas Technologies, LLC?

What the filing shows about Retropsoas Technologies, LLC

  • 38 investors had already put money in when it filed.

Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.

Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)

A Full Report on Retropsoas Technologies, LLC: verified, sourced, every claim cited, ready in a few minutes. See pricing.

What the Full Report on Retropsoas Technologies, LLC covers

  1. The Short Answer

  2. Which Company This Is

  3. What They Do, And How The Money Works

  4. Who Runs It, And How To Reach Them

  5. The Money: Funding, Valuation, Runway

  6. Who Pays Them, And Who They Are Up Against

  7. Warning Bells

  8. Sources

    2 cited sources found

Plus the sections for what you are deciding, which you pick after ordering.

See a sample report

First screen of a real sample Full Report on EchoStar: the verdict, 17 sections, 63 cited sources, built 2026-10-21A real finished report, first screen. Opens in a new tab.

The full profile

Checking your access…

Is this you?

If you're behind Retropsoas Technologies, LLC: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.

Sourced from the filing index on sec.gov.

Follow this companyRSS

Tools for this story

Each opens in a new tab, filled in for Retropsoas Technologies, LLC. With no account yet, you sign up free and land on the result.

Share this page

Is this your company?

Share your raise. This card is drawn from the company's own Form D filing, and sharing needs no account.

Retropsoas Technologies, LLC: Raised $3.11M, Form D filed 2025-01-27
Share on LinkedIn Share on X Download image

Cite this page

Permanent URL: https://mentionfox.com/funding/retropsoas-technologies-llc-form-d-25000001
Last updated 2026-11-06
Primary record: SEC filing 1 · SEC filing 2 · SEC filing 3
Retropsoas Technologies raised $3.11M — SEC Form D filing, January 2025. MentionFox, 2026-11-06. https://mentionfox.com/funding/retropsoas-technologies-llc-form-d-25000001